Crossmark

TOB-STOP-COP (TOBacco STOP in COPd trial): study protocol—a randomized open-label, superiority, multicenter, two-arm intervention study of the effect of “high-intensity” vs. “low-intensity” smoking cessation intervention in active smokers with chronic obstructive pulmonary disease

Crossref DOI link: https://doi.org/10.1186/s13063-020-04653-z

Published Online: 2020-08-21

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Saeed, Mohamad Isam https://orcid.org/0000-0002-9246-7630
Sivapalan, Pradeesh

Eklöf, Josefin

Ulrik, Charlotte Suppli

Pisinger, Charlotta

Lapperre, Therese

Tønnesen, Philip

Hoyer, Nils

Janner, Julie

Karlsson, Marie Lavesen

Bech, Charlotte Sandau

Marså, Kristoffer

Godtfredsen, Nina

Brøndum, Eva

Munk, Birgit

Raaschou, Merete

Browatzski, Andrea

Lütken, Pernille

Jensen, Jens-Ulrik Stæhr
License Information

Text and Data Mining valid from 2020-08-21

Version of Record valid from 2020-08-21
More Information

Article History

Received: 27 September 2019

Accepted: 5 August 2020

First Online: 21 August 2020

Ethics approval and consent to participate

: The study will be carried out to include the protection of human participants according to the Helsinki Declaration and in accordance with the Good Clinical Practice Guidelines. Participants will be informed about the study on inclusion day and will be included if accepting to participate. A completed patient informed consent form is required from all participants in the study and must be signed by the participant and the informing personnel. The study has been approved by the Danish Committee on Health Research Ethics (H-19013085, Report no: 67424).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below